Elysium Health, Inc.™, a leading life sciences company focused on aging research, has entered into a material transfer agreement (MTA) with the University of Oxford to examine hundreds of samples from the VITACOG study to develop epigenetic ...
Kayentis, a global provider of eCOA and Decentralized Clinical Trial solutions, today announces the launch of a fully integrated patient-centric platform that optimizes the management of hybrid and Decentralized Clinical Trials (DCT). This streamlined platform ...
APATICS, Inc. announced that co-founder, CEO and Chairman of APATICS Inc., Dimitri Arges, has stepped down to pursue other interests. Clay Wilemon has been appointed as CEO effective immediately. Mr. Arges played an instrumental role in shaping product ...
Popular Posts
